Bal Pharma Consolidated March 2023 Net Sales at Rs 82.45 crore, up 11.35% Y-o-Y
Reported Consolidated quarterly numbers for Bal Pharma are:Net Sales at Rs 82.45 crore in March 2023 up 11.35% from Rs. 74.05 crore in March 2022.
Quarterly Net Profit at Rs. 1.60 crore in March 2023 down 26.82% from Rs. 2.19 crore in March 2022.
EBITDA stands at Rs. 8.35 crore in March 2023 up 16.78% from Rs. 7.15 crore in March 2022.
Bal Pharma EPS has decreased to Rs. 1.03 in March 2023 from Rs. 1.33 in March 2022.
| Bal Pharma shares closed at 83.35 on May 29, 2023 (NSE) and has given -4.80% returns over the last 6 months and -16.69% over the last 12 months. |
| Bal Pharma | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 82.45 | 76.62 | 74.05 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 82.45 | 76.62 | 74.05 | | EXPENDITURE | | Consumption of Raw Materials | 50.67 | 40.42 | 41.13 | | Purchase of Traded Goods | 4.01 | 4.04 | 1.20 | | Increase/Decrease in Stocks | -9.58 | 0.43 | 3.29 | | Power & Fuel | -- | -- | -- | | Employees Cost | 14.63 | 14.06 | 12.99 | | Depreciation | 2.09 | 2.45 | 2.42 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 14.56 | 11.53 | 11.99 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 6.08 | 3.70 | 1.03 | | Other Income | 0.19 | 0.46 | 3.70 | | P/L Before Int., Excpt. Items & Tax | 6.26 | 4.16 | 4.73 | | Interest | 3.85 | 3.11 | 2.45 | | P/L Before Exceptional Items & Tax | 2.41 | 1.05 | 2.28 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 2.41 | 1.05 | 2.28 | | Tax | 0.79 | 0.46 | 0.09 | | P/L After Tax from Ordinary Activities | 1.62 | 0.59 | 2.19 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 1.62 | 0.59 | 2.19 | | Minority Interest | -0.02 | -0.02 | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 1.60 | 0.58 | 2.19 | | Equity Share Capital | 15.69 | 15.69 | 14.82 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 1.03 | 0.38 | 1.33 | | Diluted EPS | 1.04 | 0.38 | 1.30 | | EPS After Extra Ordinary | | Basic EPS | 1.03 | 0.38 | 1.33 | | Diluted EPS | 1.04 | 0.38 | 1.30 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
